Skip to main content

Advertisement

SpringerLink
Log in

Improving Provider Adherence to Guideline Recommendations in Heart Failure

  • Implementation (L. Rohde, Section Editor)
  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Heart failure clinical practice guidelines are fundamental and serve as framework for providers to deliver evidence-based care that correlates with enhanced patient outcomes. However, adherence, particularly to guideline-directed medical therapy, remains suboptimal for a multitude of reasons.

Recent Findings

Despite robust clinical trials, updated guidelines and an expert consensus statement from American Heart Association, American College of Cardiology, and Heart Failure Society of America registry data signal that heart failure patients do not receive appropriate pharmacotherapy and may receive an intracardiac device without prior initiation or optimization of medical therapy.

Summary

Strategies to improve provider adherence to heart failure guidelines include multidisciplinary models and appropriate referral and care standardization. These approaches can improve morbidity, mortality, and quality of life in HF patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major Importance

  1. Enciso JS, Greenberg B. Evolving issues in heart failure management. Prog Cardiovasc Dis. 2016;4(58):365–6.

    Article  Google Scholar 

  2. Hall MJ, Levant S, DeFrances CJ. Hospitalization for congestive heart failure: United States, 2000–2010. Age. 2012;65(23):29.

    Google Scholar 

  3. Ventura HO, Silver MA. Observations and reflections on the burden of hospitalizations for heart failure. Paper presented at: Mayo Clinic Proceedings 2017, 2017.

  4. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.

    Article  Google Scholar 

  5. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2015. https://doi.org/10.1161/CIR.0000000000000350.

  6. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–19.

    Article  CAS  Google Scholar 

  7. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292(3):344–50.

    Article  CAS  Google Scholar 

  8. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey de Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.

    Article  Google Scholar 

  9. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26(16):1653–9.

    Article  Google Scholar 

  10. Fonarow GC, Yancy CW, Hernandez AF, Peterson ED, Spertus JA, Heidenreich PA. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J. 2011;161(6):1024–30 e1023.

    Article  Google Scholar 

  11. Van Spall HG, Rahman T, Mytton O, et al. Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis. Eur J Heart Fail. 2017;19(11):1427–43.

    Article  Google Scholar 

  12. Fonarow GC, Yancy CW, Heywood JT. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med. 2005;165(13):1469–77.

    Article  Google Scholar 

  13. Calvin JE, Shanbhag S, Avery E, Kane J, Richardson D, Powell L. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART). Congest Heart Fail. 2012;18(2):73–8.

    Article  Google Scholar 

  14. Oertle M, Bal R. Understanding non-adherence in chronic heart failure: a mixed-method case study. Qual Saf Health Care. 2010;19(6):e37.

    CAS  PubMed  Google Scholar 

  15. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30(2):518–26.

    Article  CAS  Google Scholar 

  16. •• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137–61 Heart failure guideline update with new recommendations regarding biomarker monitoring and pharmacological therapy for heart failure with preserved ejection fraction, anemia, hypertension, and sleep-disorder breathing.

    Article  Google Scholar 

  17. Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol. 2017;14(1):30–8.

    Article  CAS  Google Scholar 

  18. Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, et al. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation. 2004;110(6):724–31.

    Article  CAS  Google Scholar 

  19. Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122(6):585–96.

    Article  Google Scholar 

  20. Blecker S, Agarwal SK, Chang PP, et al. Quality of care for heart failure patients hospitalized for any cause. J Am Coll Cardiol. 2014;63(2):123–30.

    Article  Google Scholar 

  21. Albert NM, Yancy CW, Liang L, et al. Use of aldosterone antagonists in heart failure. JAMA. 2009;302(15):1658–65.

    Article  CAS  Google Scholar 

  22. Curtis LH, Mi X, Qualls LG, et al. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. Am Heart J. 2013;165(6):979–986.e971.

    Article  CAS  Google Scholar 

  23. •• Greene SJ, Butler J, Albert NM, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72(4):351–66 Contemporary outpatient registry study examining patterns of guideline-directed medical therapy use.

    Article  Google Scholar 

  24. Jong P, Gong Y, Liu PP, Austin PC, Lee DS, Tu JV. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. 2003;108(2):184–91.

    Article  Google Scholar 

  25. Philbin EF, Weil HF, Erb TA, Jenkins PL. Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes. Chest. 1999;116(2):346–54.

    Article  CAS  Google Scholar 

  26. •• Komajda M, Cowie MR, Tavazzi L, et al. Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. 2017;19(11):1414–23 International, prospective, observation, longitudinal study demonstrating the association between good provider adherence to pharmacologic treatment guidelines and improved clinical outcomes.

    Article  CAS  Google Scholar 

  27. Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294(10):1240–7.

    Article  CAS  Google Scholar 

  28. Swedberg K, Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am J Cardiol. 1988;62(2):60A–6A.

    Article  CAS  Google Scholar 

  29. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106(17):2194–9.

    Article  Google Scholar 

  30. •• Roth GA, Poole JE, Zaha R, Zhou W, Skinner J, Morden NE. Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation. J Am Coll Cardiol. 2016;67(9):1062–9 Analysis of guideline-directed medical therapy in Medicare recipents receiving an implantable cardioverter-defibrillator for primary prevention. Key findings include suboptimal prescribing and a 20% higher relative risk of adjusted mortality rate for patients not on guideline-directed medical therapy.

    Article  Google Scholar 

  31. Adams V, Linke A, Winzer E. Skeletal muscle alterations in HFrEF vs. HFpEF. Curr Heart Fail Rep. 2017;14(6):489–97.

    Article  Google Scholar 

  32. Flynn KE, Pina IL, Whellan DJ, et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1451–9.

    Article  CAS  Google Scholar 

  33. O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439–50.

    Article  CAS  Google Scholar 

  34. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.

    Article  Google Scholar 

  35. Blumenthal JA, Babyak MA, O’connor C, et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA. 2012;308(5):465–74.

    Article  CAS  Google Scholar 

  36. Mentz RJ, Babyak MA, Bittner V, Fleg JL, Keteyian SJ, Swank AM, et al. Prognostic significance of depression in blacks with heart failure: insights from heart failure: a controlled trial investigating outcomes of exercise training. Circ Heart Fail. 2015;8(3):497–503.

    Article  Google Scholar 

  37. • Piña IL, Di Palo KE, Ventura HO. Psychopharmacology and cardiovascular disease. J Am Coll Cardiol. 2018;71(20):2346–59 State-of-the-art comprehensive review of psychotropic drugs commonly used in patients with concurrent cardiovascular disease and depression or anxiety.

    Article  Google Scholar 

  38. Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–65.

    Article  CAS  Google Scholar 

  39. • Yancy CW, Jessup M, Bozkurt B, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68(13):1476–88 Update includes recommendations for two new drug classes FDA approved in the treatment of heart failure with reduced ejection fraction.

    Article  Google Scholar 

  40. •• Yancy CW, Januzzi JL, Allen LA, et al. 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction. A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018;71(2):201–30 Practical guidance to address key issues such as medication titration, adherence, financial barriers, and care coordination.

    Article  Google Scholar 

  41. Lu L, Jackevicius CA, de Leon NK, Warner AL, Chang DS, Mody FV. Impact of a multidisciplinary heart failure postdischarge management clinic on medication adherence. Clin Ther. 2017;39(6):1200–9.

    Article  Google Scholar 

  42. Milfred-LaForest SK, Gee JA, Pugacz AM, et al. Heart failure transitions of care: a pharmacist-led post-discharge pilot experience. Prog Cardiovasc Dis. 2017;60(2):249–58.

    Article  Google Scholar 

  43. Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Assoc. 2016;5(6):e002606.

    Article  Google Scholar 

  44. Di Palo KE, Patel K, Assafin M, Piña IL. Implementation of a patient navigator program to reduce 30-day heart failure readmission rate. Prog Cardiovasc Dis. 2017;60:259–66.

    Article  Google Scholar 

  45. Strömberg A, Mårtensson J, Fridlund B, Levin LÅ, Karlsson J-E, Dahlström U. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure. Results from a prospective, randomised trial. Eur Heart J. 2003;24(11):1014–23.

    Article  Google Scholar 

  46. Ballard DJ, Ogola G, Fleming NS, Stauffer BD, Leonard BM, Khetan R, et al. Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care. Int J Qual Health Care. 2010;22(6):437–44.

    Article  Google Scholar 

  47. Panella M, Marchisio S, Demarchi M, Manzoli L, Di Stanislao F. Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial. BMJ Qual Saf. 2009;18(5):369–73.

    Article  CAS  Google Scholar 

  48. Basoor A, Doshi NC, Cotant JF, Saleh T, Todorov M, Choksi N, et al. Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure. Congest Heart Fail. 2013;19(4):200–6.

    Article  Google Scholar 

  49. Wu JR, Moser DK, De Jong MJ, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J. 2009;157(2):285–91.

    Article  Google Scholar 

  50. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–20.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY, 10461, USA

    Katherine E. Di Palo & Ileana L. Piña

  2. John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, Brisbane, Australia

    Hector O. Ventura

Authors
  1. Katherine E. Di Palo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ileana L. Piña
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hector O. Ventura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katherine E. Di Palo.

Ethics declarations

Conflict of Interest

Katherine E. Di Palo, Ileana L. Piña, and Hector O. Ventura declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Implementation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Palo, K.E., Piña, I.L. & Ventura, H.O. Improving Provider Adherence to Guideline Recommendations in Heart Failure. Curr Heart Fail Rep 15, 350–356 (2018). https://doi.org/10.1007/s11897-018-0411-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-018-0411-y

Keywords

Search

Navigation